M. Priess

Necuparanib, a multi-targeting heparan sulfate mimetic, targets tumor and stromalcompartments in pancreatic cancer

V. Farutin, C. L. Chu, Jamey Guess, 2018 .

Necuparanib, A Multitargeting Heparan Sulfate Mimetic, Targets Tumor and Stromal Compartments in Pancreatic Cancer

V. Farutin, C. L. Chu, Jamey Guess, 2018, Molecular Cancer Therapeutics.

Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody

Changyun Hu, D. Wiederschain, M. Gostissa, 2022, Oncoimmunology.

Expression of pro- and antifibrotic genes in protocol biopsies from renal allografts with interstitial fibrosis and tubular atrophy.

H. Haller, H. Kreipe, M. Mengel, 2008, Clinical nephrology.

Abstract 4532: Preclinical evaluation of JTX-1811, an anti-CCR8 antibody with enhanced ADCC activity, for preferential depletion of tumor-infiltrating regulatory T cells

Changyun Hu, M. Gostissa, E. Stack, 2020, Immunology.

Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T Cell Activation in Tumors.

D. Wiederschain, Christina Meyer, M. Gostissa, 2023, Molecular cancer therapeutics.